Chronic Myeloid Leukaemia (CML)

Chronic myeloid leukaemia (CML) is a slow-growing type of blood cancer. It develops when white blood cells in your bone marrow multiply uncontrollably. Find out about the signs and symptoms of CML, tests you might have, and how CML is diagnosed.

Learn more about CML

Download our CML factsheet

Treatment for chronic myeloid leukaemia (CML) is usually very effective. The main treatment is a targeted drug called a tyrosine kinase inhibitor (TKI). Find out about TKIs and other treatment options, including chemotherapy and stem cell transplants.

Learn more about CML treatment

Response to treatment for chronic myeloid leukaemia (CML) is usually measured using a blood test called PCR. This measures your molecular response. Find out what molecular response is and what the results mean.

Monitoring response to treatment in CML

Download our molecular response factsheet

Treatment-free remission (TFR) is when your CML stays under control without the need to keep taking medicines. It might be possible for some people with CML who have a deep, long-term response to tyrosine kinase inhibitors (TKIs). Find out about the risks and benefits, and what happens if you try it.

Learn more about TFR

Download our TFR factsheet

Order or download free factsheets, leaflets and booklets about CML.

Download our CML resources

Order our printed CML information

We aim to provide information that’s reliable, up-to-date, and covers what matters to you. Please complete our short survey to help us improve our information and make sure it meets your needs.

Complete our short survey